Two That Doubled and Now Look Ready to Break Out.. and a Third That...
We are up 234% in Ardelyx (ARDX) $5.23 since adding it to Watch List a year ago and up 71% in Cardiol...
Hundreds of Stocks Have Fallen Below $1. They’re Still Listed on Nasdaq. (WSJ)
Investor-protection advocates say many belong to risky small companies that should be on the OTC market.
With 557 names...
Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.
LQR House (LQR). And the Numbers are In!
A Situation Which Can't be Ignored!
That's not to say run out and buy it, but this current valuation...
LQR Announces Proposed Reverse Split as Part of Nasdaq Compliance Plan
LIVE QUOTE
MIAMI BEACH, FL / ACCESSWIRE / November 21, 2023 / LQR House Inc....
Institutional Analyst Initiates Coverage on LQR House ‘the Liquor House’ (NASDAQ: LQR).
Report posted below @3:11 11.13.23
LQR House (LQR) $0.09
Easily the Best and Most...
Vext Welcomes Ohio Approval of Adult-Use Cannabis Legalization
Vext currently has a fully vertically integrated footprint in Ohio with an operating Tier I cultivation facility, an operating manufacturing...
LQR House Inc. Announces Pricing of $11 Million Public Offering
MIAMI BEACH, FL / ACCESSWIRE / November 10, 2023 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), today announced the...
Full Report: Sekur Private Data (SWISF) $0.07.
Our Top Ranked Cybersecurity Speculation
A Growing Number of Users are Saying that Sekur’s Privacy and Safety...
Adding Organigram (OGI) $1.38 to Top Marijuana Companies for 2024 Watch List.
Organigram Announces $90 Million Investment from British American Tobacco (BAT).
Tale of Two Charts.
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
